Navigation Links
New Drug Appears to Extend Survival in Advanced Prostate Cancer Patients
Date:8/16/2012

p>Whether the drug will cause side effects like those seen with regular hormone therapy isn't yet known, Scher said. That's something the current trials may reveal.

The possible side effects can reduce patient's quality of life and include constipation or diarrhea, nausea, loss of or decrease in appetite, dizziness or headache, trouble sleeping, impotence, and decreased sex drive.

Enzalutamide is a type of hormonal therapy that, through another pathway, acts like traditional hormone therapy. It was created to help men who develop resistance to regular hormone therapy and go on to develop an aggressive cancer called castration-resistant prostate cancer, the most advanced form of the disease, Scher said.

Researchers found that men build resistance to hormone therapy because the tumor increases the production of androgen (a male hormone) receptors, he added.

Enzalutamide binds to androgen receptors in cancer cells, blocking the ability of these receptors to promote cancer growth, Scher explained.

If approved, enzalutamide would join a similar drug, abiraterone (Zytiga), as a new treatment for prostate cancer that is resistant to traditional hormone therapy.

Although it is too early to know how much enzalutamide will cost, the wholesale cost of abiraterone is about $5,000 a month, according to Bloomberg News. The retail cost is, of course, higher.

"This is good news for men with advanced prostate cancer," said Dr. Anthony D'Amico, chief of radiation oncology at Brigham and Women's Hospital in Boston.

"It's likely a drug that will be FDA approved," he said.

D'Amico cautioned, however, that if the drug is used in men with early prostate cancer who are prone to seizures, it needs to be carefully monitored.

"The bottom line is, it's good news," D'Amico said. "I predict in the next five to seven years we will be using drugs like this as opposed to what we currently use to treat men with earlier-stage disease."
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Off-Label Drug Use Appears Common
2. Exercise Appears to Ease Nerve-Damage Pain in Rat Study
3. New Pill Appears Effective, Safe for Ulcerative Colitis: Study
4. Healthy Behaviors Extend Life After Cancer, Experts Say
5. Exercise and a healthy diet of fruits and vegetables extends life expectancy in women in their 70s
6. New Melanoma Drug May Extend Survival
7. New treatment protocol extends survival in some cases of once inoperable pancreatic cancer
8. Spaceflight may extend the lifespan of microscopic worm
9. Gene therapy treatment extends lives of mice with fatal disease, MU study finds
10. Experimental drug may extend therapeutic window for stroke
11. Golden age of prostate cancer treatment hailed as fourth drug in 2 years extends life
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Drug Appears to Extend Survival in Advanced Prostate Cancer Patients
(Date:5/3/2015)... Leading international program provider, Child ... awarding the 2015 Harris Wofford Global Service Fellowships. CFHI ... the deserving recipients of the award named after former ... Wofford. The two recipients were chosen for their strong ... , CFHI is one of seven organizations participating ...
(Date:5/3/2015)... “ BolehVPN ” was featured on NewsWatch as part of ... technology products available to consumers. Scott Steinberg, a technology expert ... with viewers how to protect their private information. , A ... and even more so online. It helps everyone stay connected ... world. In terms of work, the internet makes things more ...
(Date:5/3/2015)... SpineFrontier, a Less Exposure Surgery (LES) technology ... and market their new sacroiliac joint fusion screw, the ... settings and is compatible with both lateral and alternate ... extensively researched and refined by SpineFrontier, the first company ... in conjunction with a sacroiliac joint fusion system like ...
(Date:5/2/2015)... one of only 30 Illinois companies to be a ... Recognition Program (SHARP) certification, Essentra Specialty Tapes ... of Labor to host this special event. The ... Occupational Safety and Health Administration’s (“OSHA”) Onsite Consultation Program ... exceed all of the necessary regulations and standards, thanks ...
(Date:5/2/2015)... ActOn ” was featured on NewsWatch as part of its ... coolest applications on the market for iOS, Android, and Windows. ... the app review and shared with viewers how this app ... difference. , In this material world, almost everything is about ... which is why those things should be prioritized above others. ...
Breaking Medicine News(10 mins):Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2
... RN, sees,herself as a "healthcare human GPS device" guiding ... passion, and when she retires,it will become her profession ... Healthcare Liaison., "For many years I have witnessed ... process of navigating the health care system,",says Shouldice, who ...
... 12 Naturlose, a natural sugar,approved as a food ingredient ... spikes of serum glucose that follow consumption of food (1). ... ) is currently,studying the efficacy and safety of Naturlose for ... Spherix has engaged market,research companies to seek feedback as to ...
... and Pandemic Influenza Initiatives Also,on the Agenda, ... Human Services (HHS) Secretary Mike Leavitt is visiting ... bilateral efforts to improve the,safety of products on ... The week-long trip to Beijing and Shanghai ...
... Fla., May 12 Dawning Technologies, Inc.,announces ... interface device in,the new JavaLin/PDI Portable Device ... intelligent clinical interfaces from Dawning and provides ... aimed at the,connection of clinical instruments to ...
... A new study in Psychology of Women Quarterly ... and girls. While girls were harassed more frequently, boys ... that tolerates the harassment of girls. , The ... University of Illinois at Urbana-Champaign, examined the relationship among ...
... health needs of women adequately addressed by medical research ... of Mayo Clinic Proceedings, a team of Australian researchers ... traditional model of medical research was limited by gender ... on white male participants could be easily extrapolated to ...
Cached Medicine News:Health News:Retiring Nurses See Healthcare Advocacy as Second Career - Healthcare Liaison Workshop June 7-8 Shows Them How to Make Transition 2Health News:Market Research Shows Spherix's Naturlose(R) Readily Accepted by Diabetes Patients 2Health News:Market Research Shows Spherix's Naturlose(R) Readily Accepted by Diabetes Patients 3Health News:Secretary Leavitt Travels to the People's Republic of China to Check Up on Efforts to Improve Product Safety 2Health News:Dawning Technologies, Inc. Releases JavaLin/PDI Portable Device Interface 2Health News:Both boys and girls negatively affected by sexual harassment 2Health News:Medical research should include more women participants and examine the role of gender in disease 2Health News:Medical research should include more women participants and examine the role of gender in disease 3
(Date:5/1/2015)... , May 01, 2015 /PRNewswire/ --Research ... the "Americas Clinical Chemistry Analyzer Market by Product, by ... The American Clinical Chemistry Analyzers market is estimated ... 2019. Countries, such as the U.S., Canada ... and Rest of Americas (RoA) are covered in this ...
(Date:5/1/2015)... 2015  Portal Instruments, Inc., an emerging leader in ... that Robert Langer, Sc. D., MIT Institute Professor, ... Distinguished Professor have joined the company,s Scientific Advisory Board. ... biotechnology leaders, Professor Robert Langer and Professor ... Patrick Anquetil , Chief Executive Officer of Portal ...
(Date:5/1/2015)...  CytRx Corporation (CYTR), a biopharmaceutical research and ... results for the three months ended March 31, ... and upcoming milestones for its clinical development programs. ... early months of 2015, including the announcement of ... in patients with soft tissue sarcoma, and positive ...
Breaking Medicine Technology:Americas Clinical Chemistry Analyzer (Semi-Automated Clinical Chemistry and Fully-Automated Clinical Chemistry) Market - Forecast to 2019 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 4CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11
... 2011 Orexigen ® Therapeutics, Inc. (Nasdaq: OREX ... Securities Healthcare Conference in New York. The presentation is scheduled for ... listen to the live webcast or a replay of the presentation, ... at www.orexigen.com . A replay will be available for 14 ...
... MONMOUTH JUNCTION, N.J., Sept. 26, 2011 Insmed Incorporated (Nasdaq ... President and CEO of Insmed, will be presenting a corporate ... Wednesday, September 28, 2011, at 11:30 AM ET, in New ... available on Insmed,s website, http://www.insmed.com .  The webcast will ...
Cached Medicine Technology:Insmed to Present at Sixth Annual JMP Securities Healthcare Conference 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: